Editing Cardinal Health (section)

=== 2020–present ===
As of August 2021, it is ranked 14 on the [[Fortune 500]] list with FY2020 annual revenue of $152.9 billion.<ref name=":1">{{Cite web|title=Cardinal Health {{!}} 2021 Fortune 500|url=https://fortune.com/company/cardinal-health/fortune500/|access-date=2021-08-16|website=Fortune|language=en}}</ref> The firm employs 48,000 people worldwide.<ref name=":1" />

==== Acquisitions ====
In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired.<ref name=":0" /> The merger represented the first non-distribution acquisition by Cardinal Health.<ref name=":0" />

In 1996, Cardinal Health acquired [[Pyxis Corporation]], a company that developed [[Automated dispensing cabinet|automated pill dispensers]] for hospitals, for $867 million.<ref>{{cite web| url=https://www.nytimes.com/1996/02/08/business/cardinal-deal-to-buy-pyxis-in-stock-swap.html| title=Cardinal Deal To Buy Pyxis In Stock Swap| last=Freudenheim| first=Milt| date=February 8, 1996| work=The New York Times| access-date=June 10, 2015}}</ref>

In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which [[McKesson Corporation]] responded with a bid to purchase Amerisource.<ref name=":2">{{Cite web|title=McKesson Plans to Buy Rival AmeriSource|website=[[Los Angeles Times]] |date=24 September 1997 |url=https://www.latimes.com/archives/la-xpm-1997-sep-24-fi-35503-story.html|url-status=live|archive-url=https://web.archive.org/web/20121107150755/http://articles.latimes.com/1997/sep/24/business/fi-35503|archive-date=7 November 2012}}</ref> Instead, Amerisource and Bergen merged into [[AmerisourceBergen]].<ref name=":2" /> Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.<ref>{{cite web| url=https://www.nytimes.com/1996/11/28/business/cardinal-health-to-purchase-owen-healthcare.html| title=Cardinal Health to Purchase Owen Healthcare| date=November 28, 1996| work=The New York Times| access-date=June 10, 2015}}</ref>

In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of [[Baxter Healthcare]]).<ref name=":0" /> In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in [[Indianapolis]].<ref>{{Cite web|date=15 February 2001|title=Cardinal Health completes Bindley Western acquisition|url=https://www.bizjournals.com/columbus/stories/2001/02/12/daily19.html|url-status=live|access-date=2021-08-16|website=www.bizjournals.com|archive-url=https://web.archive.org/web/20040417115125/http://www.bizjournals.com:80/columbus/stories/2001/02/12/daily19.html |archive-date=2004-04-17 }}</ref>

In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million.<ref>{{Cite web|last=Staff|title=Cardinal Health buying ParMed for $40.1 million|url=https://buffalonews.com/news/cardinal-health-buying-parmed-for-40-1-million/article_5c89c08b-6a1c-5830-a964-80c613f186eb.html|access-date=2021-08-20|website=The Buffalo News|date=9 March 2006 |language=en}}</ref> In June 2007, the firm announced the completion of a [[tender offer]] for VIASYS Healthcare.<ref>{{cite web| url=http://www.healthcareitnews.com/news/cardinal-health-acquires-viasys-15b| title=Cardinal Health acquires VIASYS for $1.5B| date=May 14, 2007| publisher=Healthcare IT News| access-date=June 10, 2015}}</ref>

In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million.<ref>{{cite web| url=http://www.dailyfinance.com/2010/06/09/cardinal-health-buys-healthcare-solutions/| title=Cardinal Health Pays $517 Million for Obscure Specialty Pharma Firm| last=Taulli| first=Tom| date=June 9, 2010| publisher=Daily Finance| access-date=June 10, 2015}}</ref> In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent.<ref name=wsj>Dinah Wisenberg Brin, [https://www.wsj.com/articles/SB10001424052748704104104575622363175617190 "Cardinal Health to Purchase Kinray"], ''The Wall Street Journal'', November 19, 2010</ref> From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor.<ref>{{Cite web|last=Glenn|first=Brandon|date=2010-11-29|title=Cardinal Health buys Chinese drug distributor for $470 million|url=https://medcitynews.com/2010/11/cardinal-health-buys-chinese-pharmaceuticals-distributor-for-470m/|access-date=2021-08-20|website=MedCity News|language=en-US}}</ref> Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.<ref>{{Cite web|title=Cardinal Health sells China business for $1.2B|url=https://www.bizjournals.com/columbus/news/2017/11/15/cardinal-health-sells-china-business-for-1-2.html|url-status=live|access-date=2021-08-20|website=www.bizjournals.com|archive-url=https://web.archive.org/web/20220116082737/https://www.bizjournals.com/columbus/news/2017/11/15/cardinal-health-sells-china-business-for-1-2.html |archive-date=2022-01-16 }}</ref> 

In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States.<ref name="dp14" /><ref>{{Cite web|title=Cardinal, CVS to form venture for generics|url=https://www.dispatch.com/article/20131210/NEWS/312109768|url-status=live|access-date=2021-08-20|website=The Columbus Dispatch|language=en|archive-url=https://web.archive.org/web/20210820142753/https://www.dispatch.com/article/20131210/NEWS/312109768 |archive-date=2021-08-20 }}</ref> The companies started buying generic drugs around the world to sell in U.S. markets.<ref name="dp14" />

In March 2015, Cardinal Health signed an agreement to acquire [[Johnson & Johnson]]'s [[Cordis (medical)]] division, a cardiology and endovascular device manufacturer, for $1.94 billion.<ref>{{cite web| url=http://www.dispatch.com/content/stories/business/2015/03/02/cardinal-health-buys-cordis.html| title=Cardinal Health to acquire Cordis for $1.9 billion| last=Wartenberg| first=Steve| date=March 3, 2015| publisher=The Columbus Dispatch| access-date=June 10, 2015}}</ref><ref>{{cite web| url=http://www.foxbusiness.com/industries/2015/03/02/cardinal-health-to-buy-jj-heart-business-for-14b/| title=Cardinal Health to Buy J&J's Heart Business for $1.94B| date=March 2, 2015| publisher=Fox Business| access-date=June 10, 2015| archive-url=https://web.archive.org/web/20150611203318/http://www.foxbusiness.com/industries/2015/03/02/cardinal-health-to-buy-jj-heart-business-for-14b/| archive-date=June 11, 2015| url-status=dead}}</ref> The acquisition was completed on October 4, 2015.<ref>{{cite press release|url=http://www.prnewswire.com/news-releases/cardinal-health-completes-acquisition-of-cordis-300153418.html#|title=Cardinal Health Completes Acquisition Of Cordis|first=Cardinal|last=Health|website=www.prnewswire.com|access-date=14 April 2018}}</ref> Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.<ref>{{Cite web|title=Cardinal Health to sell off its Cordis device division in $1B deal|url=https://www.fiercebiotech.com/medtech/cardinal-health-to-divest-its-cordis-device-division-1b-deal|access-date=2021-08-20|website=FierceBiotech|date=15 March 2021 |language=en}}</ref>

In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from [[Medtronic]] for $6.1 billion.<ref>{{Cite web|date=2017-04-18|title=Cardinal Health to acquire Medtronic medical supplies business for $6.1B|url=https://www.modernhealthcare.com/article/20170418/NEWS/170419874/cardinal-health-to-acquire-medtronic-medical-supplies-business-for-6-1b|access-date=2021-08-20|website=Modern Healthcare|language=en}}</ref><ref name=":3">{{Cite web|title=Medtronic closes on $6.1 billion sale of supply lines to Cardinal Health|url=https://www.startribune.com/medtronic-closes-on-6-1-billion-sale-of-supply-lines-to-cardinal-health/437690263/|access-date=2021-08-20|website=Star Tribune|date=August 2017 }}</ref> The acquisition was completed on July 30, 2017.<ref name=":3" />

In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business.<ref>{{Cite web|title=In brief: Cardinal Health to buy ADS, AMA fights prior auths, Williams Brothers names CEO|url=https://www.hmenews.com/article/in-brief-cardinal-health-to-buy-ads-ama-fights-prior-auths-williams-brothers-names-ceo|access-date=2025-04-08|website=NHM News}}</ref><ref>{{Cite press release|title=Cardinal Health announces two strategic additions to its portfolio|url=https://www.prnewswire.com/news-releases/cardinal-health-announces-two-strategic-additions-to-its-portfolio-302301928.html|access-date=2025-04-08|website=PR Newswire}}</ref> The acquisition was complete by April 2024. <ref>{{Cite web|title=Cardinal Health completes acquisition of the Advanced Diabetes Supply Group (ADSG)|url=https://newsroom.cardinalhealth.com/2025-04-01-Cardinal-Health-completes-acquisition-of-the-Advanced-Diabetes-Supply-Group-ADSG|access-date=2025-04-08|website=Cardinal Health Newsroom}}</ref>